Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership2,713,519 shares
Latest Disclosed Value $ 109,399,340
Geode Capital Management, Llc reports 1.67% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 2,713,519 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $93,589,270 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,668,918 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 1.67% during the quarter. The current value of the position is $171,602,942 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,713,519 44,601 1.67 109,399 17.77 0.0036
2026-02-09 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,668,918 734,646 37.98 92,892 -42.49 0.0031
2025-11-12 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,934,272 18,656 0.97 161,530 14.45 0.0103
2025-08-08 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,915,616 -344,447 -15.24 141,143 -45.50 0.0099
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,260,063 191,888 9.28 258,989 148.45 0.0204
2025-02-12 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,068,175 -310,583 -13.06 104,240 -5.33 0.0081
2024-11-12 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 2,378,758 99,470 4.36 110,108 48.66 0.0089
2024-08-09 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 2,279,288 121,503 5.63 74,067 36.25 0.0065
2024-05-13 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 2,157,785 112,139 5.48 54,362 -18.19 0.0050
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 2,045,646 87,959 4.49 66,450 24.57 0.0070
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,957,687 212,897 12.20 53,344 37.41 0.0064
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,744,790 -49,137 -2.74 38,822 -0.09 0.0046
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,793,927 72,426 4.21 38,856 114,182.35 0.0050
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,721,501 74,718 4.54 35 -99.92 0.0049
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,646,783 17,306 1.06 42,223 8.97 0.0064
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,629,477 -37,403 -2.24 38,748 3.22 0.0057
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,666,880 -63,992 -3.70 37,538 9.53 0.0047
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,730,872 -74,533 -4.13 34,271 -3.54 0.0041
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,805,405 -3,905 -0.22 35,530 -10.74 0.0048
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,809,310 38,105 2.15 39,804 -5.53 0.0055
2021-05-12 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,771,205 123,882 7.52 42,136 -2.22 0.0064
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,647,323 135,198 8.94 43,093 63.74 0.0072
2020-11-13 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,512,125 -11,829 -0.78 26,318 2.68 0.0052
2020-08-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,523,954 44,693 3.02 25,632 45.74 0.0055
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,479,261 46,655 3.26 17,587 1.46 0.0046
2020-02-20 2019-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 1,432,606 16,207 1.14 17,334 -13.42 0.0036
2020-02-13 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,432,606 16,207 17,334 2,209.0663
2019-11-12 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,416,399 31,927 2.31 20,020 29.70 0.0047
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,384,472 124,903 9.92 15,436 4.39 0.0037
2019-05-14 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,259,569 84,535 7.19 14,787 -5.80 0.0038
2019-03-06 2018-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 1,175,034 85,705 7.87 15,698 2.79 0.0049
2019-02-13 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,175,034 85,705 15,698
2018-11-13 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,089,329 110,170 11.25 15,272 -0.78 0.0043
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 979,159 100,904 11.49 15,392 6.54 0.0047
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 878,255 -67,095 -7.10 14,447 -15.38 0.0047
2018-02-13 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 945,350 -17,607 -1.83 17,072 -8.14 0.0058
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 962,957 98,635 11.41 18,584 82.23 0.0069
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 864,322 24,127 2.87 10,198 10.76 0.0040
2017-06-21 2017-03-31 13F/A-1 CORCEPT THERAPEUTICS INC COM COM 218352102 840,195 77,945 10.23 9,207 66.40 0.0038
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 840,195 9,207
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 762,250 99,478 15.01 5,533 28.47 0.0026
2016-11-10 2016-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 662,772 124,974 23.24 4,307 46.75 0.0022
2016-08-12 2016-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 537,798 43,650 8.83 2,935 26.95 0.0016
2016-05-13 2016-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 494,148 -191 -0.04 2,312 -6.05 0.0012
2016-02-12 2015-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 494,339 10,719 2.22 2,461 35.44 0.0014
2015-11-13 2015-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 483,620 38,147 8.56 1,817 -32.10 0.0011
2015-08-14 2015-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 445,473 2,722 0.61 2,676 7.99 0.0015
2015-05-14 2015-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 442,751 22,608 5.38 2,478 96.82 0.0014
2015-02-12 2014-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 420,143 -31,632 -7.00 1,259 4.05 0.0007
2014-11-14 2014-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 451,775 38,211 9.24 1,210 4.58 0.0008
2014-08-13 2014-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 413,564 61,180 17.36 1,157 -24.67 0.0007
2014-05-14 2014-03-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 352,384 55,908 18.86 1,536 61.01 0.0010
2014-02-14 2013-12-31 13F CORCEPT THERAPEUTICS INC COM COM 218352102 296,476 61,658 26.26 954 155.76 0.0007
2013-11-14 2013-09-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 234,818 7,583 3.34 373 -5.09 0.0003
2013-08-14 2013-06-30 13F CORCEPT THERAPEUTICS INC COM COM 218352102 227,235 227,235 393 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.